Arizona Bioscience News: C-Path announces new CEO; Emagine Solutions to increase ultrasound access; Myndshft expanding Mesa office

March 21, 2019

By Matt Ellsworth

C-Path picks global regulatory affairs leader as new CEO / AZ Big Media

After a worldwide search, Tucson-based Critical Path Institute has appointed Joseph Scheeren, Pharm. D., as its new President and Chief Executive Officer. Scheeren previously served in senior roles for Bayer AG and has had a distinguished 36-year career in drug development and regulatory approval on three continents.

Startup aims to put ultrasounds in the palm of your hand / Arizona Daily Star

Tucson-based startup Emagine Solutions Technology LLC aims to make medical imaging more accessible by adapting smartphones as inexpensive, mobile ultrasound systems.

Bioscience is creating a more stable market in Phoenix /

Bioscience and the life sciences are growing rapidly in Phoenix with the industries fueling local economic and job growth, and in the long term, they will also ensure more stability for Phoenix.

NAU’s top research rankings benefiting Flagstaff and region / Flagstaff Business News (Op-ed)

Northern Arizona University president Rita Cheng writes that for the first time, NAU is recognized as one of the top 100 research universities without a medical school by the National Science Foundation.

Something fantastic has happened in the Phoenix startup ecosystem / Phoenix Business Journal (Op-ed)

PADT Inc’s Eric Miller writes that local tech startup community supporters sat in amazement as strong startup after strong startup delivered their five-minute pitches during the annual Venture Madness event put on by Invest Southwest in partnership with the Arizona Commerce Authority. 

Mesa health-tech company moves to new office, plans to triple headcount / Phoenix Business Journal

Myndshft Technologies Inc., a Mesa-based health technology company which seeks to power the next generation of health-care administration, has expanded into a larger office and has plans to more than triple its workforce by the end of the year.

TGen develops program that lights up cancer-causing mutations / AZ Big Media

Researchers at Translational Genomics Research Institute have developed LumosVar, a computer program that can accurately identify cancer-causing mutations from patient tumor samples.

Cancer patients to have access to chemo in Verde Valley / Camp Verde Bugle

Verde Valley cancer patients will soon be able to get their chemotherapy treatments in Cottonwood and Sedona, as Northern Arizona Healthcare plans to provide medical oncology and chemotherapy infusion treatment at the Verde Valley Medical Center.

Valley woman with pancreatic cancer is a beacon of hope for others diagnosed / 12 News

A groundbreaking trial led by the HonorHealth Research Institute and TGen to treat pancreatic cancer by combining three chemotherapy drugs has led to a longer life for a Valley woman.

Aspiring Doctors Seek Advanced Training In Addiction Medicine / NPR

Medical institutions nationwide are creating fellowships for aspiring doctors who want to treat substance-use disorders with the same precision and science as other diseases. A report from Phoenix.

Upcoming Events

March 274th Annual Precision Medicine Symposium, UA Cancer Center, Tucson

Click here to sign up to receive Arizona Bioscience News